General description
Sofosbuvir, a nucleotide polymerase inhibitor, is a pan-genotypic direct acting antiviral agent for the treatment of chronic hepatitis C virus (HCV) infection.
INN
Sofosbuvir
ATC codes
Medicine type
Chemical agent
EML status history
First added in 2015
(TRS
994)
for
Chronic hepatitis C
Wikipedia
DrugBank
Recommendations
Section
Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations
- Oral > Solid: 400 mg; 200 mg
Indications